beebalm
Monarda fistulosa · Accepted scientific name
Scientific literature: Very Extensive (333 studies) · ★★★★★
Beebalm, scientifically known as Monarda fistulosa, is a versatile perennial herb celebrated for its striking lavender flowers and aromatic foliage. Renowned in traditional medicine for its antimicrobial and anti-inflammatory properties, this resilient wildflower also serves as a vital nectar source, attracting pollinators and enriching diverse natural ecosystems worldwide.
- Family
- Lamiaceae
- Native range
- Europe
- Parts used
- Flower
- Common names
- Oswego-Tea · Purple Beebalm · 5 more
- Scientific synonyms
- Not available
Names and Synonyms
Common Names
- Oswego-tea
- purple beebalm
- wild bergamot
- wild horsemint
- beebalm
- horse-mint
- wild bergamot beebalm
Scientific Names
Accepted name
Monarda fistulosaRegional and Traditional Names
Spanish:
- Monarda morada
German:
- Wilde Bergamotte
- späte Indianernessel
- Wilde Bergamotte
- Wilde Indianernessel
- Wilde Monarde
French:
- monarde fistuleuse
Sources: Wikidata, Catalogue of Life
Taxonomical Classification
This plant belongs to the kingdom Plantae and is classified under the phylum Streptophyta within the class Equisetopsida. It is further categorized under the subclass Magnoliidae and the order Lamiales, falling into the family Lamiaceae. Finally, it is identified by the genus Monarda.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Monarda |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
This plant exhibits a diverse geographical distribution spanning across both Europe and North America. In Middle Europe, it can be found growing within the borders of Germany. Its presence extends significantly into Western Canada, where it inhabits the province of British Columbia. The species is also widely distributed across the Canadian prairies, specifically in Alberta and Saskatchewan. Finally, its range reaches into the province of Manitoba, completing its broad northern reach.
| Region | Area |
|---|---|
| Middle Europe | Germany |
| Western Canada | Alberta |
| Western Canada | British Columbia |
| Western Canada | Manitoba |
| Western Canada | Saskatchewan |
| Eastern Canada | Ontario |
| Eastern Canada | Québec |
| Northwestern U.S.A. | Colorado |
| Northwestern U.S.A. | Idaho |
| Northwestern U.S.A. | Montana |
Sources: The World Checklist of Vascular Plants (WCVP)
Botanical Identification
Life history
The life history of Monarda fistulosa is characterized by a perennial lifecycle, allowing the plant to persist through multiple growing seasons. As a hemicryptophyte, its perennating buds are located at the soil surface, typically protected by leaf litter or a thin layer of organic matter during unfavorable conditions. This specific life form, categorized both as a hemicryptophyte in terms of its growth habit and structural classification, enables the species to re-emerge vigorously from its crown each spring to support its continuous developmental stages.
- Life form :
- hemicryptophyte
- Lifecycle :
- perennial
Morphology
The morphology of Monarda fistulosa is characterized by its growth form as a non-woody herb and specifically a forb. It functions as a self-supporting plant, lacking any climbing or vine-like tendencies, and it is categorized as an independent organism rather than a parasite. As a terrestrial species, it does not exhibit aquatic or epiphytic lifestyles. The plant typically reaches a mean height of approximately 1.205 m, maintaining a robust, upright structure throughout its development.
- Aquatic :
- terrestrial
- Climber :
- self-supporting
- Epiphyte :
- terrestrial
- Growth form :
- herb
- Growth form :
- forb
- Parasite :
- independent
- Plant height mean:
- 1.205 m
- Woodiness :
- non-woody
Physiology
The physiology of Monarda fistulosa is characterized by a metabolic framework primarily driven by the C3 photosynthetic pathway, which involves the direct fixation of atmospheric carbon dioxide through the enzyme RuBisCO within the mesophyll cells. This C3 mechanism dictates the plant's water-use efficiency and gas exchange patterns, as it relies on maintaining a balance between CO2 uptake and transpiration to avoid photorespiration. The plant's physiological processes are further supported by a complex secondary metabolism, specifically the biosynthesis of various monoterpenoids and phenolic compounds, which serve as chemical defenses and metabolic byproducts. These physiological activities are closely integrated with its vascular system, which facilitates the transport of water and nutrients to support its perennial growth habit and the energetic demands of its flowering cycles.
- Photosynthetic pathway :
- C3
Reproduction
The reproduction of Monarda fistulosa is characterized by a specific seasonal flowering cycle and the production of minute seeds. The flowering period typically begins in June and extends through August, though the timing can be variable depending on environmental conditions. During this reproductive phase, the plant produces seeds with a highly specific mass profile; the mean seed mass is approximately 0.000375375 g, with individual seeds ranging from a minimum of 0.0003 g (3e-04 g) to a maximum of 0.00052 g.
- Flowering time :
- Jun
- Flowering time :
- Aug
- Seed mass max:
- 0.00052 g
- Seed mass mean:
- 0.000375375 g
- Seed mass min:
- 3e-04 g
Sources: Global Inventory of Floras and Traits (GIFT)
Plant Parts
Monarda fistulosa has 1 reported plant parts identified across 2 scientific publications and several other databases that are studied for medicinal purposes. The most consistently reported plant part include flower.
| Plant part | Supporting sources | Consensus |
|---|---|---|
| Flower | 2 supporting sources | ★☆☆☆☆ |
Flower
- Molecules (Basel, Switzerland)
- Journal of medicinal food
Chemicals
Monarda fistulosa has 59 reported phytochemicals identified across 2 scientific publications and several other databases. The most consistently reported chemicals include CARVACROL, P-CYMENE, THYMOL, Thymoquinone, rosmarinic acid.
| Chemical | Supporting sources | Consensus |
|---|---|---|
| CARVACROL | 5 supporting sources | ★★★☆☆ |
| P-CYMENE | 3 supporting sources | ★★☆☆☆ |
| THYMOL | 2 supporting sources | ★☆☆☆☆ |
| Thymoquinone | 2 supporting sources | ★☆☆☆☆ |
| rosmarinic acid | 2 supporting sources | ★☆☆☆☆ |
| 1,8-Cineole | 1 supporting sources | ★☆☆☆☆ |
| 1-OCTEN-3-OL | 1 supporting sources | ★☆☆☆☆ |
| 3-OCTANOL | 1 supporting sources | ★☆☆☆☆ |
| 3-Octanone | 1 supporting sources | ★☆☆☆☆ |
| 3-Octyl acetate | 1 supporting sources | ★☆☆☆☆ |
CARVACROL
- Dr. Duke
- Molecules (Basel, Switzerland)
- Plant foods for human nutrition (Dordrecht, Netherlands)
- Current molecular pharmacology
- Biofouling
P-CYMENE
- Dr. Duke
- Molecules (Basel, Switzerland)
- Plant foods for human nutrition (Dordrecht, Netherlands)
THYMOL
- Dr. Duke
- Molecules (Basel, Switzerland)
Thymoquinone
- Dr. Duke
- Plant foods for human nutrition (Dordrecht, Netherlands)
rosmarinic acid
- Dr. Duke
- Plant foods for human nutrition (Dordrecht, Netherlands)
1,8-Cineole
- Dr. Duke
1-OCTEN-3-OL
- Dr. Duke
3-OCTANOL
- Dr. Duke
3-Octanone
- Dr. Duke
3-Octyl acetate
- Dr. Duke
Activities
Monarda fistulosa has 253 reported activities identified across 2 scientific publications and several other databases. The most consistently reported activities include (-)-Chronotropic, (-)-Inotropic, ABeta-Inhibitor, ACE-Inhibitor, AChE-Inhibitor.
| Activity | Supporting sources | Consensus |
|---|---|---|
| (-)-Chronotropic | 1 supporting sources | ★☆☆☆☆ |
| (-)-Inotropic | 1 supporting sources | ★☆☆☆☆ |
| ABeta-Inhibitor | 1 supporting sources | ★☆☆☆☆ |
| ACE-Inhibitor | 1 supporting sources | ★☆☆☆☆ |
| AChE-Inhibitor | 1 supporting sources | ★☆☆☆☆ |
| Acaricide | 1 supporting sources | ★☆☆☆☆ |
| Acidulant | 1 supporting sources | ★☆☆☆☆ |
| Adenylate-Cyclase-Inhibitor | 1 supporting sources | ★☆☆☆☆ |
| Aldose-Reductase-Inhibitor | 1 supporting sources | ★☆☆☆☆ |
| Allelochemic | 1 supporting sources | ★☆☆☆☆ |
(-)-Chronotropic
- Dr. Duke
(-)-Inotropic
- Dr. Duke
ABeta-Inhibitor
- Dr. Duke
ACE-Inhibitor
- Dr. Duke
AChE-Inhibitor
- Dr. Duke
Acaricide
- Dr. Duke
Acidulant
- Dr. Duke
Adenylate-Cyclase-Inhibitor
- Dr. Duke
Aldose-Reductase-Inhibitor
- Dr. Duke
Allelochemic
- Dr. Duke
Medicinal Uses
Monarda fistulosa has 3 reported medicinal uses identified across 2 scientific publications and several other databases. The most consistently reported uses include Gram-negative bacteria, Gram-positive bacteria, yeasts.
Most Reported Uses
| Use | Sources | Consensus |
|---|---|---|
| Gram-negative bacteria | Pharmaceutics (and other 1 sources) | ★☆☆☆☆ |
| Gram-positive bacteria | Pharmaceutics (and other 1 sources) | ★☆☆☆☆ |
| yeasts | Pharmaceutics (and other 1 sources) | ★☆☆☆☆ |
Preparations
| Preparations | Sources | Consensus |
|---|---|---|
| essential oils | Molecules (Basel, Switzerland) (and other 2 sources) | ★☆☆☆☆ |
| Flower (MEOFl) and leaf (MEOLv) essential oils | Molecules (Basel, Switzerland) (and other 1 sources) | ★☆☆☆☆ |